Teva Puts End Of 2022 Ambition On Nationwide US Opioids Settlement

‘We Believe We’re Getting Closer,’ Says CEO Kåre Schultz

 
• By Dean Rudge
  
Flags
Teva has nationwide ambitions with a trial in California to come • Source: Shutterstock: Savvapanf Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products